A great body of evidence suggests that the increased levels of HMGB1 in the CSF and in the systemic circulation, after ischemic and hemorrhagic strokes, are due to the release of HMGB1 from damaged cells that gains entry into these compartments through the disrupted BBB. This evidence concerns the gene HMGB1 and hemorrhagic stroke.